Martino R, Santamaría A, Muñoz L, Pericas R, Altés A, Prats G, Sierra J
Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Acta Haematol. 1999;102(1):7-11. doi: 10.1159/000040960.
To compare the characteristics of bacteremic infections by different aerobic gram-negative bacilli (GNB) in patients with hematologic malignancies, we studied 54 consecutive monomicrobial bacteremias by Enterobacteriaceae (EB), 15 by Pseudomonas aeruginosa, 43 by other non-glucose-fermenting GNB (NGFGNB) and 11 by other GNB. Patients with EB and P. aeruginosa bacteremia usually developed the infection after intensive chemotherapy for leukemia or during a hematopoietic stem cell transplantation, while most infections in outpatients off therapy were due to NGFGNB. A significant proportion of bacteremias by EB (37%) and P. aeruginosa (40%) were accompanied by severe morbidity (septic shock, pneumonia or deep-seated organ infections) vs. only 7% of other NGFGNB (p < 0.01). Most infections by these latter bacteria were catheter-related bacteremias (80 vs. 2% of EB, p < 0.005), while most EB infections (61%) were uncomplicated bacteremias of unknown source (vs. 14% of other NGFGNB, p < 0.005). Appropriate antibiotics alone cured 98% of EB and 73% of P. aeruginosa bacteremias but only 26% of other NGFGNB (p < 0.005 for both differences), which were cured by catheter removal in 70%, usually after failure of antibiotic treatment. In conclusion, our results suggest that there are significant differences in the patient populations and clinical characteristics of bacteremic infections by the classic GNB (EB and P. aeruginosa) and the new NGFGNB in adults with hematologic malignancies.
为比较血液系统恶性肿瘤患者中不同需氧革兰氏阴性杆菌(GNB)所致菌血症感染的特征,我们研究了54例由肠杆菌科细菌(EB)引起的连续性单微生物菌血症、15例由铜绿假单胞菌引起的菌血症、43例由其他非葡萄糖发酵GNB(NGFGNB)引起的菌血症以及11例由其他GNB引起的菌血症。EB和铜绿假单胞菌菌血症患者通常在白血病强化化疗后或造血干细胞移植期间发生感染,而门诊非治疗患者的大多数感染是由NGFGNB引起的。EB(37%)和铜绿假单胞菌(40%)所致菌血症中有很大比例伴有严重发病情况(感染性休克、肺炎或深部器官感染),而其他NGFGNB所致菌血症仅有7%伴有严重发病情况(p<0.01)。后一类细菌引起的大多数感染是导管相关菌血症(80%,而EB为2%,p<0.005),而大多数EB感染(61%)是来源不明的非复杂性菌血症(其他NGFGNB为14%,p<0.005)。单独使用合适的抗生素可治愈98%的EB菌血症和73%的铜绿假单胞菌菌血症,但只能治愈26%的其他NGFGNB菌血症(两种差异均p<0.005),对于其他NGFGNB菌血症,70%在抗生素治疗失败后通过拔除导管治愈。总之,我们的结果表明,在患有血液系统恶性肿瘤的成人中,经典GNB(EB和铜绿假单胞菌)和新型NGFGNB所致菌血症感染的患者群体和临床特征存在显著差异。